Full Text View
Tabular View
No Study Results Posted
Related Studies
Distribution of Tacrolimus in Skin, Atopic Dermatitis
This study has been completed.
Study NCT00534508   Information provided by Astellas Pharma Inc
First Received: September 21, 2007   Last Updated: December 16, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dermatitis, Atopic
Additional conditions recognized in this trial
Dermatitis
More general conditions related to this trial
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Genetic
Interventions listed in this trial
Tacrolimus Ointment 0.1%
Additional drug interventions recognized in this trial
Tacrolimus
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services